X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6199) 6199
Newspaper Article (557) 557
Newsletter (539) 539
Book Chapter (39) 39
Book / eBook (11) 11
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
prostate cancer (6130) 6130
humans (5243) 5243
science & technology (5185) 5185
male (5149) 5149
life sciences & biomedicine (4558) 4558
oncology (3049) 3049
cancer (2454) 2454
prostatic neoplasms - pathology (2394) 2394
cell line, tumor (2152) 2152
prostatic neoplasms - genetics (2091) 2091
research (1864) 1864
animals (1851) 1851
prostatic neoplasms - metabolism (1779) 1779
metastasis (1768) 1768
androgens (1487) 1487
prostate (1467) 1467
genetic aspects (1290) 1290
gene expression (1260) 1260
mice (1211) 1211
tumors (1180) 1180
urology & nephrology (1109) 1109
care and treatment (1095) 1095
development and progression (1077) 1077
gene expression regulation, neoplastic (1038) 1038
receptors, androgen - metabolism (1005) 1005
prostatic neoplasms - drug therapy (999) 999
aged (996) 996
analysis (985) 985
middle aged (967) 967
cell biology (882) 882
cancer therapies (857) 857
receptors, androgen - genetics (849) 849
proteins (810) 810
oncology, experimental (788) 788
prognosis (766) 766
endocrinology & metabolism (760) 760
health aspects (752) 752
signal transduction (747) 747
apoptosis (726) 726
prostatic neoplasms, castration-resistant - pathology (709) 709
prostatic neoplasms, castration-resistant - genetics (704) 704
research article (687) 687
disease progression (685) 685
prostatic neoplasms, castration-resistant - drug therapy (679) 679
metastases (676) 676
cell proliferation (670) 670
androgen receptor (662) 662
medicine (662) 662
science & technology - other topics (628) 628
multidisciplinary sciences (618) 618
castration (609) 609
urology (599) 599
biochemistry & molecular biology (586) 586
kinases (554) 554
urologic and male genital diseases (553) 553
biomarkers (546) 546
mutation (535) 535
chemotherapy (533) 533
patients (526) 526
medical research (519) 519
prostatic neoplasms, castration-resistant - metabolism (519) 519
science (514) 514
prostatic neoplasms - therapy (493) 493
genes (478) 478
neoplasm metastasis (467) 467
studies (466) 466
immunohistochemistry (460) 460
cell proliferation - drug effects (458) 458
mice, nude (442) 442
medical prognosis (437) 437
xenograft model antitumor assays (434) 434
cell cycle (430) 430
cell growth (418) 418
aged, 80 and over (410) 410
antineoplastic agents - pharmacology (409) 409
biomarkers, tumor - genetics (398) 398
treatment outcome (395) 395
prostate - pathology (389) 389
antineoplastic agents - therapeutic use (387) 387
biology (385) 385
physiological aspects (385) 385
deoxyribonucleic acid--dna (357) 357
signal transduction - drug effects (349) 349
stem cells (343) 343
neoplasms. tumors. oncology. including cancer and carcinogens (342) 342
physical fitness (341) 341
antigens (338) 338
review (337) 337
breast cancer (333) 333
gene expression regulation, neoplastic - drug effects (332) 332
micrornas - genetics (327) 327
prostate - metabolism (326) 326
drug therapy (325) 325
risk factors (324) 324
apoptosis - drug effects (323) 323
prostatic neoplasms - diagnosis (321) 321
medicine, research & experimental (319) 319
research & experimental medicine (319) 319
genomics (314) 314
clinical trials (313) 313
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7328) 7328
Japanese (17) 17
Chinese (11) 11
French (7) 7
Norwegian (7) 7
German (6) 6
Spanish (6) 6
Czech (1) 1
Polish (1) 1
Portuguese (1) 1
Russian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature medicine, ISSN 1546-170X, 02/2016, Volume 22, Issue 3, pp. 298 - 305
Journal Article
Journal Article
PloS one, ISSN 1932-6203, 11/2011, Volume 6, Issue 11, pp. e27970 - e27970
Background: Although androgens are depleted in castration resistant prostate cancer (CRPC... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Neoplasms, Hormone-Dependent - metabolism | Prostatic Neoplasms - metabolism | Prostatic Hyperplasia - pathology | Prognosis | Alternative Splicing | Humans | Middle Aged | Receptors, Androgen - metabolism | Gene Expression Regulation, Neoplastic | Bone Neoplasms - secondary | Male | Immunoenzyme Techniques | Prostate - metabolism | Bone Neoplasms - metabolism | Neoplasms, Hormone-Dependent - genetics | Prostate - pathology | Prostatic Neoplasms - genetics | Castration | Aged, 80 and over | Adult | Bone Neoplasms - genetics | Real-Time Polymerase Chain Reaction | Soft Tissue Neoplasms - genetics | Prostatic Neoplasms - pathology | Soft Tissue Neoplasms - secondary | RNA, Messenger - genetics | Soft Tissue Neoplasms - metabolism | Reverse Transcriptase Polymerase Chain Reaction | Prostatic Hyperplasia - genetics | Blotting, Western | Prostatic Hyperplasia - metabolism | Receptors, Androgen - genetics | Neoplasms, Hormone-Dependent - pathology | Cell Line, Tumor | Aged | Proteins | Viral antibodies | Antibodies | Androgens | Metastasis | Prostate cancer | Alternative splicing | Phosphorylation | Staining | Kinases | Tissues | Urology | Metastases | Angiogenesis | Xenografts | Localization | Medical research | Lymphatic system | Immunoglobulins | Review boards | C-Terminus | Gene expression | Polymerase chain reaction | Chemotherapy | Ligands | Immunoreactivity | Prostate | Cancer | Index Medicus
Journal Article
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 04/2016, Volume 34, Issue 12, pp. 1402 - 1418
Journal Article
Journal Article
The Journal of clinical investigation, ISSN 1558-8238, 12/2018, Volume 129, Issue 2, pp. 569 - 582
Prostate cancer (PC) progressed to castration resistance (CRPC) is a fatal disease. CRPC tumors develop resistance to new-generation antiandrogen enzalutamide... 
Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Oligonucleotide Array Sequence Analysis | Transforming Growth Factor beta3 - genetics | Humans | Male | Neoplasm Proteins - antagonists & inhibitors | Receptor, Transforming Growth Factor-beta Type I - antagonists & inhibitors | Gene Expression Profiling | Hepatocyte Nuclear Factor 3-alpha - antagonists & inhibitors | Neoplasm Proteins - metabolism | Transforming Growth Factor beta3 - metabolism | Prostatic Neoplasms, Castration-Resistant - genetics | Prostatic Neoplasms, Castration-Resistant - pathology | Quinolines - pharmacology | Receptor, Transforming Growth Factor-beta Type I - metabolism | Neoplasm Proteins - genetics | Pyrazoles - pharmacology | Signal Transduction | Hepatocyte Nuclear Factor 3-alpha - genetics | Prostatic Neoplasms, Castration-Resistant - drug therapy | Mice, SCID | Prostatic Neoplasms, Castration-Resistant - metabolism | Hepatocyte Nuclear Factor 3-alpha - metabolism | Xenograft Model Antitumor Assays | Animals | Cell Line, Tumor | Mice | Receptor, Transforming Growth Factor-beta Type I - genetics | Phosphorylation | Motility | Mesenchyme | Genomics | Genomes | Metastasis | Kinases | Metastases | Proteins | Disease resistance | Liver cancer | Genotype & phenotype | Cell growth | Castration | Smad2 protein | Cooperation | Xenografts | Plasticity | Bioinformatics | Growth factors | Phenotypes | Transforming growth factor-b1 | Gene expression | Studies | Androgens | DNA microarrays | Pheochromocytoma cells | Prostate cancer | Prostate | Tumors | Index Medicus | Abridged Index Medicus
Journal Article